C12Y 402/02021
Chondroitin-sulfate-abc exolyase
Official title: Chondroitin-sulfate-ABC exolyase (4.2.2.21)
C12Y402/02021 (Chondroitin-sulfate-abc exolyase) appears on 13 US grants and 19 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 19
- Assignees
- 7
- Inventors
- 18
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 2 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 2 |
| 2023 | 1 | 2 |
| 2024 | 2 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Targeted chondroitinase ABC fusion proteins and complexes thereof7 Jul 2026US 12,674,155 B2University of Florida Research Foundation, Inc.
- Pharmaceutical composition, package and method for producing the same18 Feb 2025US 12,226,463 B2Seikagaku Corporation
- Package and method for producing the same17 Sep 2024US 12,090,228 B2Seikagaku Corporation
- Therapeutic agent for disc herniation2 Apr 2024US 11,944,670 B2Seikagaku Corporation
- Pharmaceutical composition, package and method for producing the same16 May 2023US 11,648,299 B2Seikagaku Corporation
- Pharmaceutical composition, package and method for producing the same5 Jun 2025US 2025/0177499 A1Seikagaku Corporation
- Therapeutic agent for disc herniation16 Jan 2025US 2025/0018018 A1Seikagaku Corporation
- Package and method for producing the same5 Dec 2024US 2024/0398712 A1Seikagaku Corporation
- Pharmaceutical composition, package and method for producing the same24 Aug 2023US 2023/0263871 A1Seikagaku Corporation
- Chondroitinase abc mutants and methods of manufacture and use thereof23 Mar 2023US 2023/0091945 A1The Governing Council of the University of Toronto
Most cited
By later US patents
- Compositions and methods of using chondroitinase ABCI mutants3US 7,722,864 B2Acorda Therapeutics, Inc. · 2010
- Compositions and methods of using chondroitinase ABCI mutants1US 8,404,232 B2Acorda Therapeutics, Inc. · 2013
- Compositions and methods of using chondroitinase ABCI mutants1US 9,102,930 B2Acorda Therapeutics, Inc. · 2015
- Compositions and methods of using chondroitinase ABCI mutants1US 9,410,141 B2Acorda Therapeutics, Inc. · 2016